Form 4: Guardant Health Executive Chris Freeman Reports Stock Transactions
SEC Form 4 Filing
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.
Summary
- On March 15, 2025, Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., reported transactions involving common stock and restricted stock units.
- Freeman acquired 1,401 shares of common stock upon the vesting of restricted stock units.
- 387 shares were disposed of to cover tax withholding obligations at a price of $42.89 per share.
- Following these transactions, Freeman directly owns 39,803 shares of common stock and 7,010 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates standard compensation practices involving stock-based compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| June 9, 2023 | Date of restricted stock unit award grant. |
| June 15, 2024 | 33% of the shares subject to the restricted stock unit award vested. |
| March 15, 2025 | Date of stock transactions: vesting of restricted stock units and tax withholding. |
| March 18, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.